These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33346120)

  • 1. Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice.
    Walker CK; Greathouse KM; Boros BD; Poovey EH; Clearman KR; Ramdas R; Muhammad HM; Herskowitz JH
    Neuroscience; 2021 Feb; 455():195-211. PubMed ID: 33346120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice.
    Hoffmann NA; Dorostkar MM; Blumenstock S; Goedert M; Herms J
    Acta Neuropathol Commun; 2013 Dec; 1():82. PubMed ID: 24344647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau.
    Dickstein DL; Brautigam H; Stockton SD; Schmeidler J; Hof PR
    Brain Struct Funct; 2010 Mar; 214(2-3):161-79. PubMed ID: 20213269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy.
    Ono M; Komatsu M; Ji B; Takado Y; Shimojo M; Minamihisamatsu T; Warabi E; Yanagawa T; Matsumoto G; Aoki I; Kanaan NM; Suhara T; Sahara N; Higuchi M
    Aging Cell; 2022 Jul; 21(7):e13615. PubMed ID: 35662390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice.
    Xu H; Rösler TW; Carlsson T; de Andrade A; Bruch J; Höllerhage M; Oertel WH; Höglinger GU
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):833-43. PubMed ID: 24865638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
    Brody AH; Nies SH; Guan F; Smith LM; Mukherjee B; Salazar SA; Lee S; Lam TKT; Strittmatter SM
    Mol Neurodegener; 2022 May; 17(1):32. PubMed ID: 35501917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.
    Buccarello L; Grignaschi G; Castaldo AM; Di Giancamillo A; Domeneghini C; Melcangi RC; Borsello T
    J Alzheimers Dis; 2017; 56(4):1279-1292. PubMed ID: 28157099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice.
    Bittner T; Fuhrmann M; Burgold S; Ochs SM; Hoffmann N; Mitteregger G; Kretzschmar H; LaFerla FM; Herms J
    PLoS One; 2010 Nov; 5(11):e15477. PubMed ID: 21103384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease.
    Kandimalla R; Manczak M; Yin X; Wang R; Reddy PH
    Hum Mol Genet; 2018 Jan; 27(1):30-40. PubMed ID: 29040533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional deletion of ROCK2 induces anxiety-like behaviors and alters dendritic spine density and morphology on CA1 pyramidal neurons.
    Weber AJ; Adamson AB; Greathouse KM; Andrade JP; Freeman CD; Seo JV; Rae RJ; Walker CK; Herskowitz JH
    Mol Brain; 2021 Nov; 14(1):169. PubMed ID: 34794469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep Disruption Precedes Forebrain Synaptic Tau Burden and Contributes to Cognitive Decline in a Sex-Dependent Manner in the P301S Tau Transgenic Mouse Model.
    Martin SC; Joyce KK; Lord JS; Harper KM; Nikolova VD; Cohen TJ; Moy SS; Diering GH
    eNeuro; 2024 Jun; 11(6):. PubMed ID: 38858068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated sarcopenia precedes learning and memory impairments in the P301S mouse model of tauopathies and Alzheimer's disease.
    Longo S; Messi ML; Wang ZM; Meeker W; Delbono O
    J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1358-1375. PubMed ID: 38646816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
    Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
    FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
    Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
    Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
    Ponnusamy M; Wang S; Yuksel M; Hansen MT; Blazier DM; McMillan JD; Zhang X; Dammer EB; Collier L; Thinakaran G
    Brain; 2023 Apr; 146(4):1561-1579. PubMed ID: 36059072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice.
    Zhao S; Fan Z; Zhang X; Li Z; Shen T; Li K; Yan Y; Yuan Y; Pu J; Tian J; Liu Z; Chen Y; Zhang B
    Neurotherapeutics; 2023 Mar; 20(2):452-463. PubMed ID: 36422837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study.
    Ahmad F; Mein H; Jing Y; Zhang H; Liu P
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.
    Ou W; Yang J; Simanauskaite J; Choi M; Castellanos DM; Chang R; Sun J; Jagadeesan N; Parfitt KD; Cribbs DH; Sumbria RK
    J Neuroinflammation; 2021 Dec; 18(1):312. PubMed ID: 34972522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.